Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How BI 1819479 is Taken up and Processed by the Body
Sponsor: Boehringer Ingelheim
Summary
This trial is intended to investigate the mass balance, metabolism, and basic pharmacokinetics of BI 1819479 (C-14) (Part A) and to investigate the absolute bioavailability of BI 1819479 (Part B) in healthy male volunteers.
Official title: A Phase I, Open-label, Two-part Trial to Investigate the Mass Balance, Metabolism, and Basic Pharmacokinetics of BI 1819479 (C-14) Administered as an Oral Solution (Part A) and to Investigate the Absolute Bioavailability of BI 1819479 Administered as a Film-coated Tablet Together With an Intravenous Microtracer Dose of [14 C]BI 1819479 (Part B) in Healthy Male Volunteers
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
7
Start Date
2025-08-04
Completion Date
2025-11-04
Last Updated
2026-08-21
Healthy Volunteers
Yes
Conditions
Interventions
[14C]BI 1819479
\[14C\]BI 1819479
BI 1819479
BI 1819479
BI 1819479 (C-14)
BI 1819479 mixed with \[14C\]BI 1819479
Locations (1)
Quotient Sciences
Nottingham, United Kingdom